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Introduction
RNase mitochondrial RNA processing (MRP) is an essential ri-
bonucleoprotein endoribonuclease that cleaves RNA substrates 
in a site-specifi  c manner and is highly conserved in eukaryotes 
in sequence and structure (Piccinelli et al., 2005). In the yeast 
Saccharomyces cerevisiae, RNase MRP consists of an RNA 
core, encoded by the nuclear gene NME1, and at least 11 protein 
subunits (Schmitt and Clayton, 1992; Salinas et al., 2005). Nine 
of these proteins are shared with a second highly conserved en-
doribonuclease called RNase P, which is involved in pre-tRNA 
processing (Chamberlain et al., 1998). The two protein subunits 
unique to RNase MRP are an RNA binding protein, encoded 
by the gene SNM1, and a recently identifi  ed protein, Rmp1p 
(Schmitt and Clayton, 1994; Salinas et al., 2005).
In S. cerevisiae, as in mammalian cells, RNase MRP RNA 
is found in at least two subcellular organelles. In mitochon-
dria, RNase MRP cleaves RNA transcripts complementary to 
the origin of replication, forming the RNA primer required for 
transcription-driven mitochondrial DNA replication (Lee and 
Clayton, 1998). In the nucleolus, RNase MRP specifi  cally cleaves 
27SA preribosomal RNA at the A3 site, forming the 5.8S(s) 
  ribosomal RNA (rRNA; Schmitt and Clayton, 1993; Lygerou 
et al., 1996). More recent research has uncovered a novel func-
tion for RNase MRP in cell cycle regulation (Cai et al., 2002). 
Mutations in RNase MRP components cause a cell cycle delay 
in late mitosis characterized by large budded cells, a dumbbell-
shaped nucleus, and extended spindles. Analyses determined 
that RNase MRP directly cleaves the 5′-untranslated region 
(UTR) of the yeast B-type cyclin, CLB2 mRNA, allowing for 
rapid degradation by the 5′ to 3′ exoribonuclease Xrn1p (Gill 
et al., 2004). Cleavage of the 5′-UTR of CLB2 mRNA and subse-
quent degradation by Xrn1p is a unique mode of mRNA turn-
over in S. cerevisiae. The cell cycle delay observed in RNase 
MRP mutants can be explained by the elevated CLB2 mRNA 
levels causing sustained levels of the Clb2p past anaphase, the 
stage at which Clb2p is normally degraded through ubiquitina-
tion by the anaphase promoting complex (APC; Yeong et al., 
2000). This results in prolonged Clb2p/Cdk activity, delaying 
the completion of mitosis. Degradation of the CLB2 mRNA by 
RNase MRP fi  ne tunes the system, allowing for rapid simulta-
neous degradation of both the mRNA and the protein.
It is thought that RNase MRP is predominantly localized 
to the nucleolus; however, degradation of CLB2 mRNA is pre-
sumed to occur in the cytoplasm. In addition, it is unknown how 
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essential ribonucleoprotein endoribonuclease that 
functions in the degradation of speciﬁ  c mRNAs in-
volved in cell cycle regulation. We have investigated 
where this processing event occurs and how it is regu-
lated. As expected, results demonstrate that RNase MRP 
is predominantly localized in the nucleolus, where it 
  processes ribosomal RNAs. However, after the initiation 
of mitosis, RNase MRP localizes throughout the entire 
nucleus and in a single discrete cytoplasmic spot that 
persists until the completion of telophase. Furthermore, 
this spot was asymmetrically found in daughter cells, 
where the RNase MRP substrate, CLB2 mRNA, localizes. 
Both the mitotic exit network and fourteen early ana-
phase release pathways are nonessential but important 
for the temporal changes in localization. Asymmetric lo-
calization was found to be dependent on the locasome. 
The evidence suggests that these spots are specialized 
processing bodies for the degradation of transcripts that 
are cell cycle regulated and daughter cell localized. We 
have called these TAM bodies for temporal asymmetric 
MRP bodies.
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RNase MRP activity against the CLB2 mRNA is regulated, as 
the enzyme is required to be active throughout the cell cycle 
to process rRNAs. To investigate this, we examined the in vivo 
localization of RNase MRP in yeast. We fi  nd that its localiza-
tion is cell cycle controlled, exiting the nucleolus during mitosis 
and localizing to a single punctate cytoplasmic foci in daughter 
cells. We propose that it is in these foci that the CLB2 mRNA 
is being degraded.
Results
RNase MRP localizes to the nucleolus, the 
nucleus, and a punctate cytoplasmic spot
In previous experiments, a Pop3p-GFP fusion was used to visu-
alize the localization of RNase MRP. This produced a diffuse 
nuclear staining pattern indicative of poor association with the 
RNase MRP complex (Cai et al., 2002), and similar results were 
seen with an Snm1p-GFP fusion (unpublished data). So that 
RNase MRP localization could be more clearly defi  ned, a GFP-
tagged version of the Pop1p subunit under control of the actin 
promoter (pTD125 GFP-Pop1p; Table I) was introduced as a 
reporter for RNase MRP. [ID]TBL1[/ID] Because Pop1p is a protein compo-
nent of both RNase MRP and RNase P, both complexes are vi-
sualized with this reporter. A wild-type strain carrying this 
plasmid had a strong fl  uorescent GFP signal, the majority of 
which localized in the nucleus with occasional punctate cyto-
plasmic staining. Within the nucleus, a more concentrated GFP 
fl  uorescence was observed that was presumed to be the nucleo-
lus. This was confi  rmed by introduction of a second plasmid 
producing a DsRed1 fusion to the Nop1 protein (Fig. 1; Gadal 
et al., 2001). [ID]FIG1[/ID] Nop1p is a protein known to localize to the nucle-
olus (Tollervey et al., 1991). This plasmid was used in all sub-
sequent experiments to identify the nucleolus. Merging the 
GFP and DsRed images indicates that GFP-Pop1p and DsRed-
Nop1p colocalized (Fig. 1), consistent with RNase MRP and 
RNase P localizing to the nucleolus (Bertrand et al., 1998). 
However, cytoplasmic GFP signal was never seen to overlap 
with the Nop1p signal.
The GFP-Pop1p fusion was able to complement the le-
thality of a deletion of the POP1 gene. Indeed, yeast carrying 
this as their only version of the POP1 gene grew at normal rate 
at a variety of temperatures and had no apparent defect in rRNA 
processing or tRNA processing. In addition, visualization of the 
GFP-Pop1p was identical with or without a wild-type copy of 
POP1 being present. This indicates that the GFP-Pop1 is fully 
functional and is assembled into active RNase MRP and P com-
plexes. Several fusions to the carboxy terminus of the Pop1 cod-
ing region were tested, but all of them were unable to complement 
a deletion of the POP1 gene and were hence inappropriate for 
these studies (Lygerou et al., 1994; unpublished data).
Because Pop1p is also a subunit of RNase P, it was impor-
tant to demonstrate that RNase MRP localized to all of the sites 
seen, as opposed to only a subset of them. To accomplish this, 
GFP was fused to Rmp1p, a protein component unique to RNase 
MRP. The resulting fl  uorescent Rmp1p localized to the nucleus, 
the nucleolus, and the punctate cytoplasmic spots in a fashion 
identical to the GFP-Pop1p (Fig. 1). However, as the fl  uorescent 
signal rapidly bleached, the GFP-Pop1p was used for all subse-
quent localization experiments. Like the GFP-Pop1p fusion, the 
Rmp1p fusion was found to fully complement a strain deleted 
for the corresponding wild-type gene (unpublished data).
Nucleolar localization of RNase MRP is consistent with 
its known role in rRNA processing (Schmitt and Clayton, 
1993). However, knowing that RNase MRP cleaves the 5′-UTR 
of the CLB2 mRNA to promote its rapid degradation, it was 
diffi  cult to speculate how this was occurring in the nucleolus 
(Gill et al., 2004). Because CLB2 mRNA only needs to be de-
graded at a certain time in the cell cycle, we examined whether 
the localization of RNase MRP changes as a cell divides. Wild-
type cells (TLG205) at various stages of the cell cycle were ex-
amined for their localization pattern (Fig. 2). [ID]FIG2[/ID] The stages of the 
cell cycle were defi  ned by bud size and location of the nucleus 
relative to the bud neck. RNase MRP remained in the nucleolus 
until the nucleolus began to move into the bud neck. At that 
time, RNase MRP localization appears homogeneous through-
out the nucleus. After the nucleus had completely divided and 
the mitotic spindle had disassembled, RNase MRP moved back 
into the nucleolus, as indicated by colocalization with the 
DsRed-Nop1p.
While following RNase MRP localization throughout the 
cell cycle, we observed the consistent presence of a punctate 
spot localized in the cytoplasm of many, but not all, cells in 
an asynchronous culture. Hundreds of midlog, asynchronous, 
Figure 1.  Localization of the RNase MRP protein subunits, Pop1 and 
Rmp1, to the nucleolus. GFP-Pop1 and -Rmp1 proteins predominantly local-
ize to a discrete location in the nucleus. This is also the location of the 
nucleolar protein Nop1 as indicated by a DsRed-Nop1 protein. A small 
amount of signal is detected throughout the nucleus. In addition, punctate 
cytoplasmic staining was seen with both the Pop1 and Rmp1 proteins 
(arrow). DIC, differential interference contrast. Bars, 5 μm.
Table I. Plasmids used for localization studies
Plasmid Description Source
pTD125 pTD125[URA3 CEN ACT1p-GFP-MCS-
 ACT1t]
D. Amberg
pTD125 GFP:POP1 pTD125[URA3 CEN ACT1p-GFP-POP1-
 ACT1t]
This study
pUN100DsRedNOP1 pUN100[LEU2 CEN4 DsRED-NOP1] O. Gadal
pAH1 pRS305[LEU2 SPC42-CFP] D. Amberg
pRP1085 pRS415[LEU2 CEN6 LSM1-RFP-PGK1 
 3 ′UTR]
R. Parker
pRP1152 pRS416[URA3 CEN6 DCP2-RFP] R. Parker
pTG003 pRS315[LEU2 CEN6 DCP2-RFP] This study
pTG005 pTD125[URA3 CEN ACT1p-GFP-RMP1-
 ACT1t]
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wild-type cells were examined, which revealed a pattern as to 
the appearance and localization of this foci. To rule out the pos-
sibility that the spots were random GFP aggregates, the local-
ization of RNase MRP to cytoplasmic foci was quantitatively 
followed throughout the cell cycle. Cells in G1 phase, S phase, 
metaphase, anaphase, early telophase, and late telophase were 
scored for the presence of a cytoplasmic spot and the presence 
of the spot in the mother or daughter cell. The results, sum-
marized in Fig. 2, confi  rm the observation that the localization 
of RNase MRP to cytoplasmic foci was a temporally regulated 
event. RNase MRP localization to a cytoplasmic spot was also 
seen in wild-type cells carrying the Rmp1p reporter for RNase 
MRP. The spot does not appear until the nucleus starts to move 
through the bud neck (metaphase) and can be seen through the 
end of the cell cycle. The spot was never seen in unbudded (G1 
phase) or small budded (S phase) cells or cells arrested with 
hydroxyurea in S phase. Only a single spot was seen in nearly 
all cells. More than two spots were never seen in a wild-type 
strain. Interestingly, the spot localized to the daughter cell in 
>94% of cells counted. Because the RNase MRP–containing 
spot appears in a cell cycle–controlled manner and only in the 
daughter cell, we have named it the TAM body, for temporal 
asymmetric MRP body.
TAM bodies contain RNase MRP 
and not RNase P
Snm1 is a unique protein component of RNase MRP that is 
not shared with RNase P. Previous work has identifi  ed several 
temperature-conditional mutations in this essential gene (Cai 
et al., 1999). Two of the mutations, snm1-172 and -P18, have 
been shown to have several genetic interactions with mitotic 
exit and cyclin mutations (Cai et al., 2002). In addition, these 
were the fi  rst RNase MRP mutants found to display a cell cycle 
delay in telophase (Cai et al., 1999). To determine whether 
Snm1 has a role in localization of the complex to TAM bodies, 
we investigated the localization of RNase MRP in these muta-
tions. As can be seen in Fig. 3, the snm1-P18 mutant is defective 
in localization of the complex to both the TAM body and in 
concentration of the complex in the nucleolus. [ID]FIG3[/ID] In this mutant, 
only a homogenous nuclear signal was seen and punctate 
  cytoplasmic staining was never seen. This is in contrast to the 
snm1-172 mutant, which displayed a pattern indistinguishable 
from wild type. Loss of TAM body localization in the snm1-P18 
mutant also indicates that RNase P does not localize with RNase 
MRP to these cytoplasmic spots. If RNase P also localized to 
the TAM bodies, its localization should not have been disrupted 
in the snm1 mutant.
The TAM body is a processing body 
(P body)–like structure
The specifi  c localization of the TAM body suggested that it 
might be the daughter cell spindle pole body. To determine 
whether the TAM body colocalized with the spindle pole body, 
a wild-type strain was transformed with a CFP-tagged version 
of the spindle pole component Spc42p (pAH1; Helfant, 2002). 
The TAM body was found to be a distinct focus from that of 
either of the two spindle pole bodies. This was consistently seen 
in all cells examined, indicating that the TAM body is not the 
daughter cell spindle pole (unpublished data).
Previous research has demonstrated that CLB2 mRNA is 
degraded by the exoribonuclease Xrn1p after the 5′-UTR 
Figure 2.  Intracellular localization of RNase MRP changes as cells pass 
through the cell cycle. Wild-type exponentially growing yeast cells were 
examined for RNase MRP localization at different stages of the cell cycle 
(representative images are shown). The punctate cytoplasmic spot or TAM 
body is evident beginning in metaphase. The table indicates the percent-
age of cells with cytoplasmic spots at various stages of the cell cycle and 
the percentage of those spots that are found in daughter cells. The numbers 
in parentheses are the actual counts of random cells. DIC, differential inter-
ference contrast. Bars, 5 μm.
Figure 3.  RNase MRP is mislocalized in an snm1 mutant. RNase MRP was 
localized as in Fig. 2 in a wild-type strain, TLG254 (SNM1 [WT]), or the 
temperature-sensitive snm1 mutant strains TLG256 (snm1-172) and TLG258 
(snm1-P18). RNase MRP in the snm1-172 carrying strain localized similar 
to wild type, but the snm1-P18 mutation failed to give either nucleolar or 
TAM body localization. DIC, differential interference contrast. Bar, 5 μm.JCB • VOLUME 173 • NUMBER 1 • 2006  38
is cleaved by RNase MRP (Cai et al., 2002; Gill et al., 2004). 
An xrn1∆ strain accumulates RNase MRP cleavage products 
that are most likely incompetent for translation, as they have no 
5′-cap. Many of the proteins involved in decapping mediated 
mRNA degradation, including Xrn1p, localize to cytoplasmic 
foci called P bodies. The decapping activator, Dhh1p, has been 
shown to display a signifi  cant increase in the size and number of 
P bodies that it localizes to in an xrn1∆ (Sheth and Parker, 
2003). This too is caused by an accumulation of uncapped 
mRNAs that are incompetent for translation and are accumulat-
ing with the mRNA degradation machinery in P bodies. In an 
xrn1∆ strain examined with the reporter GFP-Pop1p, the same 
phenomenon occurs. There is a clear increase in the number of 
TAM bodies (two to fi  ve per cell; Fig. 4 A) compared with wild 
type, which has only one spot in most of the cells examined. [ID]FIG4[/ID] 
Localization of the TAM bodies also differs from wild type in 
that the TAM bodies are present in both the mother and daugh-
ter cells. This result suggests that RNase MRP is processing 
mRNAs in the TAM bodies and that the degradation products 
are now accumulating in those sites.
These results led us to predict that RNase MRP may also 
localize to P bodies. Because Xrn1p works with RNase MRP to 
degrade the CLB2 mRNA, we predicted that it would colocalize 
if mRNAs were degraded in the TAM body (Gill et al., 2004). 
Xrn1p has already been shown to be a P body component that 
degrades mRNAs after decapping. We generated an Xrn1-
  RedStar2 fusion and introduced it into a wild-type strain with 
the GFP-Pop1 reporter. As can be seen in Fig. 4 B, the Xrn1p 
localized to several discrete foci in cells. In addition, we saw 
clear colocalization of a single Xrn1p spot with the TAM body. 
This indicates that the TAM body is a form of P body.
We wanted to determine whether the TAM body was a 
discrete entity or a P body that adds certain degrading activities 
(RNase MRP) at certain times in the cell cycle. To test this, the 
same xrn1∆ strain was transformed with RFP-Lsm1p (pRP1085), 
an activator of the Dcp1p–Dcp2p decapping complex known to 
localize to P bodies (Sheth and Parker, 2003). Interestingly, we 
observed that GFP-Pop1p and RFP-Lsm1p do not colocalize 
(unpublished data), suggesting that RNase MRP is not a P body 
component. To confi  rm these results, we also examined the lo-
calization of GFP-Pop1p and Dcp1p-RFP (pTG003) throughout 
the cell cycle in wild-type cells. As is evident (Fig. 5 A), the two 
proteins do not colocalize at any stage of the cell cycle, indicat-
ing that they are distinct cytoplasmic foci. [ID]FIG5[/ID] These results indicate 
that the Xrn1p protein is associated with the TAM body and that 
the TAM body may represent a specialized form of a P body in-
volved in degrading specifi  c mRNAs. Yet, the TAM bodies are 
distinct from the P bodies involved in general mRNA decapping 
and degradation.
The RNase MRP mutation nme1-p6 
has genetic interactions with mutations 
in mRNA degradation
We have reported that the RNase MRP mutant, nme1-p6 
(a strong temperature-sensitive point mutation in the gene for the 
MRP RNA) is synthetically sick in combination with an xrn1∆ 
mutation. CLB2 mRNA accumulates in an xrn1∆ mutant, and in 
an nme1-p6/xrn1∆ double mutant it rises to a level >15-fold 
higher than wild type (Gill et al., 2004). Because the TAM body 
appears to be a specialized type of P body, we investigated 
  genetic interactions of the nme1-p6 mutation with other genes 
encoding P body components and genes involved in mRNA 
degradation. The yeast strain yJA203, in which the chromo-
somal copy of NME1 is replaced with the nme1-p6 mutant 
allele, was mated to strains deleted in genes for LSM1, LSM6, 
LSM7, POP2, PAT1, and CCR4. Haploid double mutants were 
selected and tested for synthetic lethality or sickness as indi-
cated by a lack of growth or compromised growth compared 
with each of the single mutants. As can be seen in Fig. 5 B, the 
nme1-p6 mutant displayed synthetic genetic interaction with 
all of the P body components tested, including lsm1∆, lsm6∆, 
lsm7∆, pat1∆, pop2∆, and ccr4∆. These results suggest that 
both pathways are potentially interdependent and intercon-
nected. Cytoplasmic exosome components displayed no syn-
thetic interactions with the MRP RNA component, whereas a 
deletion of the nuclear exosome component rrp6∆ was syn-
thetic lethal with the nme1-P6 mutation (unpublished data). 
This result was not unexpected because Rrp6p is involved in 
5.8S rRNA processing.
RNase MRP localization in fourteen early 
anaphase release (FEAR) and mitotic exit 
network (MEN) mutants
Localization of RNase MRP to distinct cytoplasmic foci occurs 
during the late stages of the cell cycle. To fine tune the 
appearance and duration of TAM bodies during mitosis and to 
potentially identify cell cycle components regulating its local-
ization, we examined GFP-Pop1p localization in various FEAR 
and MEN mutant strains (Dumitrescu and Saunders, 2002). 
These strains arrest at slightly different points late in mitosis. 
Figure 4.  TAM bodies are P body like and colocalize with Xrn1. (A) The 
number of TAM bodies increases in an xrn1 deletion strain. The increase 
in the number of GFP ﬂ  uorescing spots indicates that deletion of this exo-
ribonuclease affects the number of TAM bodies per cell, similar to what 
is seen for P bodies. (B) Xrn1 localized with the TAM body. An Xrn1-
RedStar2 fusion was used to localize the Xrn1 protein, whereas RNase 
MRP was localized using the GFP-Pop1p reporter. Xrn1 displayed multiple 
discrete cytoplasmic spots in both the mother and daughter cells, consistent 
with its role as a P body component. However, one of the daughter cell 
spots typically overlapped with the TAM body. DIC, differential interfer-
ence contrast.REGULATED MRNA DEGRADATION IN YEAST • GILL ET AL. 39
In addition, wild-type strains were arrested using hydro  xy-
urea to provide an S phase arrest and nocodazole to pro  vide 
a premitotic arrest. Yeast strains with mutations in cdc5-1 
(TLG208), cdc14-1 (TLG285), cdc15-1 (TLG206), and esp1-1 
(TLG277) were grown at 25°C to midlog phase and shifted to 
34°C for 2–3 h. Arrested cells were counted and scored for the 
presence and localization of a TAM body in the mother or 
daughter cell. The results are summarized in Fig. 6 A. [ID]FIG6[/ID] As ex-
pected, there were no TAM bodies in cells arrested with hy-
droxyurea. This is consistent with a previous examination of 
asynchronous cultures. Nocodazole-arrested cells with a nu-
cleus still in the mother did not have TAM bodies, whereas 
those that had a nucleus in the daughter cell or trapped between 
the two cells usually did (unpublished data). Because of the dif-
fi  culty in separating the two phenotypes, quantitation was not 
done. Because the mother cell–localized nucleus indicates a 
premitotic cell and the others indicate a failed mitosis with the 
addition of nocodazole, the results are consistent with the ap-
pearance of the TAM bodies immediately or soon after the be-
ginning of mitosis.
We postulated that Esp1p might be important for RNase 
MRP release from the nucleolus. Esp1p is a protease that 
cleaves the cohesions to initiate chromosome segregation and 
the FEAR pathway. Esp1p and the FEAR pathway are very 
important in the initial release of Cdc14p from the nucleolus 
(Dumitrescu and Saunders, 2002). The esp1-1 mutant arrests 
between metaphase and the onset of anaphase. In this strain, 
40% of the arrested cells had a TAM body, 94% of which local-
ized to the daughter cell. This is comparable to what is seen in 
the wild-type strain (Fig. 2). This result indicates that RNase 
MRP is released before initiation of the FEAR pathway. 
Cdc15p is a protein kinase necessary for the MEN pathway. 
Cdc5p is also a protein kinase that plays a role in the FEAR 
and MEN pathways. Previously, overexpression of Cdc5p was 
shown to suppress some RNase MRP mutations, whereas the 
cdc5-1 mutation was synthetically lethal or sick with other mu-
tations (Cai et al., 2002). Yeast strains with the cdc5 or -15 mu-
tations arrest late in mitosis upon a shift to the nonpermissive 
temperature. Both cdc5 and -15 mutants arrested with a high 
percentage of cells having TAM bodies, similar to what is seen 
in wild-type telophase cells. In addition, the TAM bodies were 
restricted to daughter cells. The only cell cycle mutant we 
tested that differed from wild type was cdc14. Cdc14 is a pro-
tein phosphatase located at the end of both the FEAR and MEN 
pathways. Previously, the cdc14-1 mutant was shown to be 
synthetically lethal with a mutation in the RNase MRP protein 
component Snm1 (Cai et al., 2002). In the cdc14-1 mutant, 
there was a minor decrease in the number of TAM bodies and 
a small change in the asymmetry, with 83% of the TAM bodies 
localizing to the daughter cell as compared with 94% in a wild-
type strain (Fig. 6 A).
The cdc14, -15, and -5 mutations were also examined for 
levels of CLB2 mRNA. The presence of signifi  cant amounts of 
CLB2 mRNA would indicate that RNase MRP is hampered in 
TAM body localization or is unable to promote CLB2 mRNA 
degradation. As can be seen in Fig. 6 B, levels of CLB2 mRNA 
are elevated in an RNase MRP mutant as has been shown 
previously (Cai et al., 2002). CLB2 mRNA levels were found to 
be elevated in the cdc14 mutant compared with the cdc5 and -15 
mutants, which arrest at similar points in the cell cycle. This is 
consistent with it playing a role in the activation of RNase 
MRP for mRNA degradation and localization. The cdc5 
and -15 mutants displayed low levels of CLB2 mRNA. To en-
sure that sufficient levels of nucleolar RNase MRP remain 
during mitosis, we examined the processing of the 5.8S rRNA 
(Fig. 5 C). Movement of RNase MRP to the TAM body may 
Figure 5.  The TAM body is a specialized P body. (A) Simultaneous localization of both GFP-Pop1p and Dcp2p-RFP (the catalytic subunit of the decapping 
enzyme) indicate that they do not overlap. Micrographs of cells at various stages of the cell cycle were taken to determine that the TAM and P bodies are 
distinct cytoplasmic foci. Bar, 5 μm. (B) An RNase MRP mutant is synthetic lethal with mutations in P body components. A strain carrying an integrated copy 
of the nme1-P6 mutation and a wild-type NME1 gene on a URA3 plasmid was crossed to a variety of strains deleted for different P body components. 
  Haploid strains derived from the crosses that contained both mutations were tested for the ability to lose the wild-type NME1-containing plasmid by plating 
on 5-FOA. Strains are directly compared with the single mutants. Failure to grow indicates a synthetic lethality or synthetic growth defect. DIC, differential 
interference contrast.JCB • VOLUME 173 • NUMBER 1 • 2006  40
lead to a reduction in processing of the nucleolar substrate. 
However, no changes in processing of the 5.8S rRNA were seen 
in any of the cell cycle mutants, even after 2 h at the nonpermis-
sive temperature, indicating that suffi  cient RNase MRP enzyme 
remains in the nucleolus to continue rRNA processing.
Daughter cell localization of the TAM body 
is dependent on the locasome
The locasome is a complex of proteins that utilizes the actin 
  cytoskeleton to localize specifi  c mRNAs to the daughter cell 
(Gonsalvez et al., 2005). Asymmetrically localized mRNAs in-
clude CLB2 and ASH1 mRNAs (Gonsalvez et al., 2005). To de-
termine whether TAM body localization is dependent on the 
locasome, we examined the localization of the GFP-Pop1p re-
porter in strains with deletion mutations for two of the proteins 
of the locasome, myo4∆ and she2∆. Cultures were grown to 
midlog phase and examined for the presence and localization of 
TAM bodies. In each strain, RNase MRP properly localized to 
the nucleus and nucleolus, as can be seen in the myo4∆ strain in 
Fig. 7 A. [ID]FIG7[/ID] RNase MRP also localized to the TAM bodies at the 
correct time in the cell cycle. However, the TAM bodies no lon-
ger localized asymmetrically to the daughter. In myo4∆ and 
she2∆ strains, the TAM body localized to the daughter cell in 
only 29.7 and 41.4% of cells, respectively, as compared with 
94% in wild type, indicating that localization has become ran-
dom. Interestingly, a small number of unbudded cells ( 5%) 
also contained TAM bodies.
Because the CLB2 mRNA is both an RNase MRP sub-
strate and an asymmetrically localized RNA, we examined 
whether daughter cell localization of RNase MRP was depen-
dent on the presence of the CLB2 mRNA. RNase MRP may be 
using the CLB2 mRNA to carry it out to the daughter cell. How-
ever, we saw no changes in daughter cell localization or timing 
of TAM bodies in a clb2∆ (unpublished data).
The RNase MRP mutation nme1-P6 was also combined 
with the myo4∆ mutation to test for genetic interactions. As can 
be seen in Fig. 7 B, the double nme1-P6/myo4∆ strain grew 
considerably slower than either of the individual mutations. 
This genetic interaction indicates that localization of TAM bod-
ies to daughter cells is not essential, but it is important for effi  -
cient mRNA degradation, especially when RNase MRP activity 
is limiting. However, we saw no change in levels of the CLB2 
mRNA in a strain carrying a myo4∆ (unpublished data).
Discussion
RNase MRP is cell cycle regulated
RNase MRP is an evolutionarily conserved ribonucleoprotein 
endoribonuclease that performs several RNA processing events. 
We recently described a role for this endoribonuclease in degrad-
ing the CLB2 mRNA. A failure to degrade the CLB2 mRNA leads 
to persistent mRNA levels and consequently sustained Clb2 pro-
tein levels. This keeps the yeast Cdk active and delays exit from 
the cell cycle (Cai et al., 2002; Gill et al., 2004). We have dem-
onstrated here that the activity of RNase MRP against mRNAs 
appears to be regulated during the cell cycle by changes in in-
tracellular   localization. Because RNase MRP must be active and 
localized to the nucleolus throughout the cell cycle to process 
rRNAs, changes in its localization are a simple and effi  cient means 
to regulate the activity of this enzyme against specifi  c substrates.
Figure 6.  Analysis of RNase MRP in mitotic exit mutant strains. 
Complete strain genotypes can be found in Table II. Wild-type (WT), nme1-P6, 
cdc5, cdc14, and cdc15 strains were grown in rich medium to a density 
of 0.5–1.0 × 10
7 cells/ml at 25°C. (A) Presence of TAM bodies at vari-
ous cell cycle arrest points. Strains carrying the indicated mutation and a 
GFP:Pop1 reporter were arrested at the nonpermissive temperature or with 
hydroxyurea (HU). Cells indicative of the arrest point were scored for the 
presence of TAM bodies and for daughter cell localization. Numbers indi-
cate percentage with TAM bodies and total cell counts. (B, top) Northern 
analysis for CLB2 mRNA. (bottom) Ethidium bromide staining of the gel 
before transfer, indicating the RNA loading. The mutant from which the 
RNA was derived is indicated above each lane. Percentage of wild-type 
CLB2 mRNA was calculated from the intensity of bands in the northern 
analysis and standardizing against the 18S rRNA. (C) Analysis of steady-
state levels of the 5.8S rRNA. Total cellular RNA was separated on a 6% 
acrylamide gel and visualized with ethidium bromide. A change in the 
ratio of the 5.8S small (S) and large (L) RNAs results from a deﬁ  ciency in 
RNase MRP activity.
Figure 7.  The locasome is required for the asymmetry of TAM bodies. 
(A) RNase MRP was localized as in Fig. 2 in a strain deleted for the myo4∆ 
gene. The GFP-Pop1 protein was still localized to the nucleolus and to a 
punctate cytoplasmic spot during mitosis. However, the TAM bodies were 
found in both the mother and daughter cells. Similar results were found 
with the she2 mutant. Bar, 5 μm. (B) The nme1-P6 mutation was combined 
with the myo4∆, as in Fig. 5 B, to examine genetic interactions. Slow 
growth of the double mutant on media with 5-FOA indicates a synthetic 
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The data indicate that RNase MRP localizes to a discrete 
spot in the cytoplasm. The earliest signs of this spot are imme-
diately after the initiation of mitosis. The spot often appears to 
emanate from the nucleus as it pushes into the daughter cell but 
then clearly becomes a separate entity. The spot can be seen 
very late into the cell cycle in telophase cells. However, once 
septation has occurred, cytoplasmic localization is never seen. 
Occurrence of the discrete spot coincides with the disappear-
ance of CLB2 mRNA (Spellman et al., 1998), suggesting that 
the TAM body is the site of CLB2 mRNA degradation. Clb2 
protein appears to be degraded in two waves, the fi  rst wave be-
ing at the initiation of mitosis by Cdc20p and the APC and the 
second wave coming at the end of mitosis by Cdh1 and the APC 
(Yeong et al., 2000). Degradation of the CLB2 mRNA during 
the fi  rst wave would be essential for proper regulation of Clb2 
protein levels.
Late in the cell cycle, RNase MRP loses its concentrated 
nucleolar localization and localizes homogenously throughout 
the nucleus. The nucleolus never breaks down in yeast as 
indicated by Nop1p staining and the continuation in ribosome 
biogenesis (Bernstein and Baserga, 2004), so the reason behind 
the changes in nuclear staining are unclear. It may correspond 
to an unknown processing event by RNase MRP or P, as we 
cannot differentiate between RNase P and MRP in the 
nuclear fl  uorescence.
Specialized P bodies
In yeast, most mRNA is very effi  ciently exported out of the 
nucleus and is found in the cytoplasm. Hence, localization of 
RNase MRP to the cytoplasm is consistent with it degrading the 
CLB2 mRNA and other mRNAs in that locale (Gill et al., 2004). 
Several recent reports have identifi  ed similar discrete cytoplas-
mic spots in several organisms from yeast to humans (Sheth and 
Parker, 2003; Kedersha et al., 2005; Liu et al., 2005). These 
spots, called P bodies, contain much of the machinery for 
mRNA degradation and are believed to be the site of removal of 
mRNAs. Exponentially growing yeast cells typically contain be-
tween 4 and 10 P bodies that are seen throughout the cell cycle. 
We found that although RNase MRP localizes in a spot with the 
Xrn1 nuclease, it does not localize with the decapping-
  enzyme Dcp2 or the decapping-accessory protein Lsm1. Xrn1p 
has been directly shown to participate with RNase MRP in 
mRNA degradation. These results indicate that P bodies may be 
specialized for various functions. Some P bodies that perform 
traditional decapping and constitutive degradation of mRNA 
may be present throughout the cell cycle, whereas other P bod-
ies that initiate degradation through mRNA-specifi  c endoribo-
nucleases are present only during certain times or conditions. 
We propose that one such specialized P body contains the 
RNase MRP nuclease and is present only in single copy during 
mitosis. The initial study that identifi  ed P bodies in yeast dem-
onstrated that localization with different P body components 
gave different numbers of P bodies per cell (Sheth and Parker, 
2003). The signifi  cance of this was not clear at the time but may 
indicate further specialization of these particles. Likely there 
are other types of specialized P bodies that may perform other 
regulated mRNA degradation functions.
A temperature-sensitive mutation in the RNase MRP 
RNA, nme1-P6, is synthetic lethal or synthetic sick with several 
P body components. The explanation for this phenotype is two-
fold. First, compromising the regulated MRP-dependent mRNA 
degradation pathway may make certain messages completely 
dependent on the constitutive pathway for mRNA degradation. 
This is clearly the case for the genetic interactions with a dele-
tion of dcp2∆ and lsm1∆. The lsm1∆/nme1-P6 double mutant 
grew extremely slowly, and we were unable to make a strain 
heterozygous for the nme1-P6 mutation and deleted for dcp2∆ 
(unpublished data). The second explanation for the phenotype 
is if some of these components participate with RNase MRP in 
degradation of certain mRNAs. This is clearly the case for the 
Xrn1 exonuclease, which has been shown to degrade RNase 
MRP cleavage products (Gill et al., 2004). The fact that there is 
an increase in the number of TAM bodies in an xrn1∆ strain and 
that Xrn1p localizes to the TAM bodies indicates that CLB2 
mRNA degradation occurs there.
The synthetic lethality of the nme1-p6/ccr4∆ double mu-
tant may be caused by the accumulation of mRNAs that cannot 
be degraded because they have not been deadenylated or are de-
graded at a much slower rate by an alternate pathway. This may 
also hold true for the nme1-p6/pop2∆ because Pop2p is a regu-
lator of deadenylation (Coller and Parker, 2004).
Cell cycle regulation
We examined several cell cycle arrest conditions to determine in 
detail the timing and control of RNase MRP relocalization. 
TAM bodies were never seen in cells arrested with hydroxy urea 
during S phase or with nocodazole before mitosis, consistent 
with RNase MRP release being a postmitotic event. Localiza-
tion was also examined in strains with mutations in several cell 
division cycle regulators that work at the end of mitosis. These 
include esp1 (the yeast separase), cdc5 and cdc15 (protein ki-
nases in the FEAR and MEN pathways), and cdc14 (the protein 
phosphatase at the end of both the FEAR and MEN pathways). 
TAM bodies were seen in all of these mutants, indicating that 
Figure 8.  Model for regulation of RNase MRP during the cell cycle. RNase 
MRP is localized to the nucleolus through most of the cell cycle. During 
  mitosis, RNase MRP localizes into the nucleoplasm and into the cytoplasm, 
where it collects asymmetrically in the daughter cell TAM body via the 
Myo4–She pathway. Localization to the TAM body allows for degradation 
of daughter cell–localized mRNAs, such as the CLB2, that need to be de-
graded during mitosis. Both the Snm1 protein component of RNase MRP 
and the cell cycle phosphatase, Cdc14, appear to be important for the 
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RNase MRP remains relocalized through the end of mitosis. 
However, the cdc14 mutant displayed a clear reduction in the 
percentage of arrested cells with TAM bodies. The activity of the 
Cdc14 phosphatase is clearly not required for RNase MRP regu-
lation, but it may be required for full localization and activity. 
This is consistent with elevated levels of the CLB2 mRNA in 
an arrested cdc14-1 mutant. Cdc14p could be involved in both 
  release and relocalization of RNase MRP. Cdc14p and several 
other mitotic exit regulators display strong genetic interaction 
with mutations in RNase MRP components (Cai et al., 2002). 
Future studies to examine the exact cell cycle regulators that 
lead to RNase MRP relocalization will be interesting. Loss of 
Table II. S. cerevisiae strains used in this study
Strain Genotype Source
DBY2006 MATα his3-∆200 leu2-3,112 ura3-52 trp1-∆1 ade2-1 Schmitt and Clayton, 1992
DBY2007 MATa lys2 his3-∆200 leu2-3,112 ura3-52 trp1-∆1 Schmitt and Clayton, 1992
MES111-140 MATα his3-∆200 leu2-3,112 ura3-52 trp1-∆1 nme1-∆2::TRP1 pMES140[LEU2 CEN NME1] Schmitt and Clayton, 1994
MES111-P6 MATα his3-∆200 leu2-3,112 ura3-52 trp1-∆1 nme1-∆2::TRP1 pMES140-P6[LEU2 CEN nme1-P6] Schmitt and Clayton, 1994
MES116 MATα lys2-801 his3-∆200 leu2-3,112 ura3-52 trp1-∆1 nme1-∆2::TRP1 pMES127[URA3 CEN NME1] Schmitt and Clayton, 1992
MES117 MATa lys2-801 his3-∆200 leu2-3,112 ura3-52 trp1-∆1 nme1-∆2::TRP1 pMES127[URA3 CEN NME1] Schmitt and Clayton, 1992
THR200 MATa ade2 his3-∆200 leu2-3,112 trp1-∆1 ura3-52 snm1-∆1::HIS3 pTH101[URA3 CEN SNM1] Cai et al., 1999
TLG105 MATα xrn1-∆1::KANR nme1-∆2::TRP1 ade2-1 leu2-3,112 trp1-∆1 his3-∆200 ura3-52pMES127[URA3 CEN NME1] Gill et al., 2004
TLG153 MATα xrn1-∆1::KANR nme1∆2::TRP1 ade2-1 leu2-3,112 trp1-∆1 his3-∆200 ura3-52 pMES140[LEU2 CEN NME1]  Gill et al., 2004
TLG205 MATα ade2-1 leu2-1,112 trp1-∆1 his3-∆200 ura3-52 pUN100[LEU2 CEN4 DsRED-NOP1] pTD125[URA3 CEN GFP-POP1] This study
TLG206 MATα ade2-1(or ade1) leu2-3,112 trp1-∆1 his3-∆200 ura3-52 cdc15-1 pUN100[LEU2 CEN4 DsRED-NOP1] 
  pTD125[URA3 CEN GFP-POP1]
This study
TLG208 MATa ade2-1(or ade1) leu2-3,112 trp1-∆1 his3-∆200 ura3-52 cdc5-1 pUN100[LEU2 CEN4 DsRED-NOP1] pTD125[URA3 CEN 
 GFP-POP1]
This study
TLG212 MATα ade2-1 leu2-1,112 trp1-∆1 his3-∆200 ura3-52 pTD125[URA3 CEN GFP-POP1] This study
TLG216 MATa ade2 his3-∆200 leu2-3,112 trp1-∆1 ura3-52 snm1-∆1::HIS3 pTC120[LEU2 CEN SNM1] pTD125[URA3 CEN GFP-POP1] Cai et al., 1999
TLG217 MATa ade2 his3-∆200 leu2-3,112 trp1-∆1 ura3-52 snm1-∆1::HIS3 pTC172[LEU2 CEN snm1-172] pTD125[URA3 CEN GFP-POP1] Cai et al., 1999
TLG218 MATa ade2 his3-∆200 leu2-3,112 trp1-∆1 ura3-52 snm1-∆1::HIS3 pTHR100-p18
  [LEU2 CEN snm1-p18] pTD125[URA3 CEN GFP-POP1]
Cai et al., 1999
TLG254 MATa ade2 his3-∆200 leu2-3,112 trp1-∆1 ura3-52 snm1-∆1::HIS3 pTC120[LEU2 CEN SNM1] pTD125[URA3 CEN GFP-POP1] 
  pRS314[TRP1 CEN6 DsRED-NOP1]
This study
TLG255 MATa ade2 his3-∆200 leu2-3,112 trp1-∆1 ura3-52 snm1-∆1::HIS3 pTC172[LEU2 CEN snm1-172] pTD125[URA3 CEN GFP-
  POP1] pRS314[TRP1 CEN6 DsRED-NOP1]
This study
TLG258 MATa ade2 his3-∆200 leu2-3,112 trp1-∆1 ura3-52 snm1-∆1::HIS3 pTHR100-p18[LEU2 CEN snm1-p18] pTD125[URA3 
  CEN GFP-POP1] pRS314[TRP1 CEN6 DsRED-NOP1]
This study
TLG262 MATα ade2-1 leu2-1,112 trp1-∆1 his3-∆200 ura3-52 pTD125[URA3 CEN GFP-POP1] pAH1[pRS305(LEU2) SPC42-CFP] This study
TLG265 MATα ade2-1 leu2-1,112 trp1-∆1 his3-∆200 ura3-52 pAH1[pRS305(LEU2) SPC42-CFP] This study
TLG277 MATa esp1-1 leu2-3,112 his3-11,15 ura3 ade2-1 can1-100 CDC14-3HA pTD125[URA3 CEN GFP-POP1]  This study
TLG285 MATa ade2-1 leu2-1,112 trp1-∆1 his3-∆200 ura3-52 cdc14-1 pTD125[URA3 CEN GFP-POP1] pUN100[LEU2 CEN4 DsRED-NOP1] This study
TLG287 MATa his3-∆0 leu2-∆0 met15-∆0 ura3-∆0 xrn1-∆0 pTD125[URA3 CEN GFP-POP1] This study
TLG289 MATα ade2-1 leu2-1,112 trp1-∆1 his3-∆200 ura3-52 pTD125[URA3 CEN GFP-POP1] pTG003[LEU2 CEN Dcp2p-RFP] This study
TLG291 MATa his3-∆0 leu2-∆0 met15-∆0 ura3-∆0 xrn1-∆0 pTD125[URA3 CEN GFP-POP1] pTG003[LEU2 CEN Dcp2p-RFP] This study
TLG293 Mat α leu2-1,112 trp1-∆1 his3-∆200 ura3-52 pTG003[LEU2 CEN Dcp2p-RFP] This study
TLG295 MATa his3-∆0 leu2-∆0 met15-∆0 ura3-∆0 xrn1-∆0 pTG003[LEU2 CEN Dcp2p-RFP] This study
TLG312 MATα ade2-1 leu2-3,112 trp1-∆1 his3-∆200 ura3-52 pTD125[URA3 CEN GFP-POP1] pRP1085 This study
TLG314 MATa his3-∆0 leu2-∆0 met15-∆0 ura3-∆0 xrn-∆0 pTD125[URA3 CEN GFP-POP1] pRP1085 This study
TLG316 MATa lys2 ade2-1 his3-∆200 leu2-3,112 ura3-52 trp1-∆1 pTD125[URA3 CEN GFP-POP1] This study
TLG318 MATa lys2 ade2-1 his3-∆200 leu2-3,112 ura3-52 trp1-∆1 pTD125[URA3 CEN GFP-POP1] pUN100[LEU2 CEN4 DsRED-NOP1] This study
TLG321 MATa his3∆1 ura3∆0 leu2∆0 lys2∆0 or met15∆0 she2::KanMX4 This study
TLG324 MATa his3∆1 ura3∆0 leu2∆0 lys2∆0 or met15∆0 myo4::KanMX4 This study
TLG334 MATa his3-∆200 leu2-3,112 ura3-52 trp1-∆1 XRN1-RedStar2-natNT2r This study
TLG336 MATa his3-∆200 leu2-3,112 ura3-52 trp1-∆1 XRN1-RedStar2-natNT2r pTD125[URA3 CEN GFP-POP1] This study
YJA203 MATa his3∆1 ura3∆0 leu2∆0 lys2∆0 can1
r mfa1-Prmfa1-SpHis3
+ NME1::nme1-p6:NAT pJA203 [URA3:NME1] This study
BY4741 MAT α his3∆1 ura3∆0 leu2∆0 met15∆0 orf::KanMX4 Euroscarf
KLS109  MATa/α his3∆1/his3∆1 leu2∆0/leu2∆0 ura3∆0ura3∆0 met15∆0/MET15 LYS2/lys2∆0 YLR145W/YLR145W:KanMX 
  pKLS109[CEN LEU2 YLR145W]
Salinas et al., 2005
TLG343 MATa/α his3∆1/his3∆1 leu2∆0/leu2∆0 ura3∆0ura3∆0 met15∆0/MET15 LYS2/lys2∆0 YLR145W/YLR145W:KanMX 
  pTG005[URA CEN GFP-RMP1]
This study
TLG348 MATa/α his3∆1/his3∆1 leu2∆0/leu2∆0 ura3∆0ura3∆0 met15∆0/MET15 LYS2/lys2∆0 YLR145W/YLR145W:KanMX 
  pTG005[URA CEN GFP-RMP1] pUN100[LEU2 CEN4 DsRed-NOP1]
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proper localization in mutations in the RNase MRP–specifi  c 
protein Snm1 may indicate that this protein is key in regulating 
the relocalization pattern. Indeed, Rmp1pp, the other specifi  c 
protein, may play an important role.
Asymmetric RNase MRP localization
Cytoplasmic localization of RNase MRP was reserved to a sin-
gle spot. Interesting, that spot was exclusively localized to the 
daughter cell. A mother cell spot was seen in <6% of cells ex-
amined and was usually found in the rare cell that had two spots. 
Identical to the RNase MRP complex, CLB2 mRNA is asym-
metrically localized to daughter cells (Gonsalvez et al., 2005). 
Localization of CLB2 mRNA is dependent on the locasome 
(Gonsalvez et al., 2005). The locasome is a complex of several 
proteins that uses the actin cytoskeleton to transport >30 differ-
ent mRNAs into daughter cells. Our results indicate that this 
complex is also necessary for localization of RNase MRP to 
daughter cells. Deletion of the locasome components myo4 or 
she2 leads to a loss of asymmetric RNase MRP localization.
Whether RNase MRP localizes to the daughter cell by 
associating with the locasome or with locasome-associated 
mRNAs is not clear. We tested to determine whether localization 
of RNase MRP was dependent of the CLB2 mRNA and found it 
was not. However, this does not exclude RNase MRP from trav-
eling with a different RNA. The RNase MRP mutant nme1-P6 
was found to be synthetically sick with a deletion in the myo4 
gene, indicating that daughter cell localization of RNase MRP 
is important for its activity in mRNA degradation. Localization 
of RNase MRP to the site of its mRNA substrate adds an elegant 
mechanism of regulating and refi  ning cell cycle control.
RNA degradation as an ancient form 
of cell cycle regulation
RNase MRP, like its homologue RNase P, is an ancient en-
zyme that is thought to be a vestigial leftover from the RNA 
world (Orgel, 1986). These enzymes perform ancient process-
ing jobs, including the production of tRNAs, the initiation 
of DNA replication, and the production of ribosomes. In the 
world of today, proteins mainly control cell cycle regulation. 
These proteins often lead to posttranslational modifi  cations 
of other proteins, producing a plethora of effects from enzy-
matic activation and inhibition to degradation or relocaliza-
tion. However, before proteins evolved, cells required a means 
of cell cycle regulation. Enzymes that degraded or synthesized 
various RNAs that performed other enzymatic functions would 
be the simplest mechanism. The identifi  cation of RNase MRP 
functioning in regulating the cell cycle by degrading specifi  c 
mRNAs adds credence to this hypothesis. Indeed, regulated 
localization of an RNA enzyme to its site of action or substrate 
adds an additional level of regulation that could have been per-
formed in the RNA world.
Model for RNase MRP regulation
Three lines of evidence suggest that TAM bodies are the sites of 
RNase MRP–directed mRNA degradation. First, the temporal 
appearance of the TAM bodies coincides with the time of deg-
radation of the CLB2 mRNA. Second, deletion of the Xrn1p 
nuclease leads to accumulation of RNase MRP–cleaved CLB2 
mRNA (Gill et al., 2004). The accumulation of RNase MRP 
products and, hence, Xrn1p substrates is probably what leads to 
the increase in TAM body numbers. Third, asymmetric localiza-
tion of RNase MRP is consistent with previous reports of asym-
metric localization of the CLB2 mRNA. There are clearly other 
important mRNA substrates of RNase MRP (Cai et al., 2002; 
Gill et al., 2004). It will be interesting if they are also asymmet-
rically localized.
In our model, the initiation of mitosis produces a signal 
for the release of RNase MRP from the nucleolus (Fig. 8). [ID]FIG8[/ID ] 
Clearly, the Cdc14 phosphatase and Snm1p play some role in 
the relocalization or activation of RNase MRP for mRNA deg-
radation. Substantial levels of RNase MRP must remain behind 
in the nucleolus to continue rRNA biogenesis, and this is indi-
cated because neither nucleolar localization of RNase MRP nor 
RNase MRP–dependent rRNA processing are lost. Once RNase 
MRP localizes to the cytoplasm, daughter cell localization ap-
pears to be mediated by the locasome. It is not clear whether 
the locasome is specifi   cally carrying RNase MRP into the 
daughter cell or if it is being transported with one of its sub-
strates or the entire TAM body. Once in the TAM body, the evi-
dence suggests that certain mRNAs, including the CLB2 
mRNA, are degraded. Degradation of these RNAs by RNase 
MRP and Xrn1p may actually lead to breakdown of the TAM 
body and relocalization of RNase MRP back into the nucleus 
and then the nucleolus.
Materials and methods
Strains
A list of yeast strains used in this study is provided in Table II. [ID]TBL2[/ID] Strain 
construction and basic molecular biology techniques were performed 
as described previously (Sambrook and Russell, 2001). The Escherichia 
coli strain used for cloning, DH5α, has the genotype ϕ80dlacZ∆M15 
endA1 recA1 hsdR17 (rk− mk+) supE44 thi-1 λ
− gyrA96 relA1 ∆(lacIZYA-
argF)U169 F
−. The yeast strain TLG334 (Table II) was made by integrating 
RedStar2, a red ﬂ  uorescent protein tag, at the XRN1 chromosomal locus. 
The RedStar2 tag was ampliﬁ  ed off the toolbox plasmid pYM-43 (Janke 
et al., 2004) using the primers OXRN/S2 (5′-TAT ACT ATT AAA GTA 
ACC TCG AAT ATA CTT CGT TTT TAG TCG TAT GTT CTA ATC GAT GAA 
TTC GAG CTG G-3′) and OXRN/S3 (5′-AAG TCA CAA AGC AAT GCT 
GCT GAC CGT GAT AAT AAA AAA GAC GAA TCT ACT CGT ACG 
CTG CAG GTC GAC-3′). The resulting PCR product was integrated into 
fresh, competent wild-type cells (DBY2006) using the Li Acetate method 
(Cai et al., 1999). After the transformation was complete, the cells were 
resuspended in YPD medium (1% yeast extract, 2% peptone, and 2% dex-
trose) and incubated at 30°C overnight. The cells were then concentrated, 
resuspended in TE, pH 7.5, and spread on medium containing 100 μg/ml 
of nourseothricin.
Plasmids
The plasmids used for ﬂ   uorescence microscopy are listed in Table I. 
pTD125 and pUN100DsRedNOP1 were gifts from D. Amberg (State 
University of New York Upstate Medical University, Syracuse, NY) and 
O. Gadal (Institut Pasteur, Paris, France), respectively. To construct 
pTG003, pRP1152 [pRS416, Dcp2:RFP:pgkterm] (a gift from R. Parker, 
University of Arizona, Tucson, AZ; Sheth and Parker, 2003) was digested 
with the restriction enzymes HindIII and SacI to isolate the DNA fragment 
containing the DCP2p:RFP:pgkterm fusion and cloned into the HindIII and 
SacI sites of pRS315 (Sikorski and Hieter, 1989). Subsequent transforma-
tions and analyzes were performed as described previously (Sambrook 
and Russell, 2001).
To make plasmid pTD125 GFP:POP1, the POP1 gene was ampli-
ﬁ  ed off the plasmid pTC101 using the primers OTC4 (5′-CTC GTC GAC 
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TCC ATG AGC GGGA GTTT GTC TAG AG-3′). The resulting 2.7-kb 
fragment containing POP1 was cloned into the BamHI and SalI sites of 
pTD125 (Doyle and Botstein, 1996). Plasmid pTG105 was constructed 
by cloning the RMP1 structural gene into the HindIII and BamHI sites of 
pTD125. RMP1 was generated by PCR from the plasmid p33/pMES-
145RMP1 (Salinas et al., 2005) using the primer ORMP1/Bam(for) 
(5′-AT ATA GGA TCC ATG GAT GAG ATG GAT AAT GTG-3′) and the 
reverse primer ORMP1-2 (5′-AA AAA AGC TTA TCC GAA TAT GCC 
ATC AAT GGC-3′).
Yeast cultures and microscopy
For ﬂ   uorescence microscopy, strains were grown in SCD (2% dextrose, 
0.5% ammonium sulfate, 0.17% yeast nitrogen base, 50 μg/ml phenylala-
nine, 40 μg/ml tryptophan, 30 μg/ml lysine, 20 μg/ml methionine, 
40 μg/ml adenine, 20 μg/ml histidine, 30 μg/ml leucine, and 20 μg/ml
uracil) lacking leucine and uracil for plasmid selection and supplemented 
with adenine (20 μg/L) to reduce the ﬂ  uorescence background that can 
occur in strains with an ade2 mutation. A 3-ml aliquot of SCD (−leucine, 
−uracil, +adenine) media inoculated with a single colony was grown at 
30°C for 20–24 h. A 10-μl aliquot of the overnight culture was passed into 
fresh media and grown another 20–24 h at 30°C. The second overnight 
culture was then used to inoculate 20 ml of SCD media and grown to 
a density of 0.5–1.0 × 10
7 cells/ml. Live cells with ﬂ  uorescent-tagged 
  proteins were examined on an Axioskop 2 (Carl Zeiss MicroImaging, Inc.) 
at 100× magniﬁ  cation using a digital camera (ORCA-ER; Hamamatsu) to 
capture single-focal plane images. All images were processed using 
  Openlab software (Improvision). Final ﬁ  gures were generated using Photo-
shop software (Adobe).
Yeast cell arrest experiments
Wild-type strain TLG205 was used for hydroxyurea arrest experiments. In 
each experiment, cell cultures were grown to early log phase (0.3–0.7 × 10
7 
cells/ml) in deﬁ   ned SCD media (described in the previous section). 
  Hydroxyurea was added directly to the 20-ml culture for a ﬁ  nal concentra-
tion of 10 mg/ml. The culture was incubated at 30°C for an additional 
3 h, at which time  90% of the cells were arrested as medium budded cells. 
Strains carrying the cell division cycle mutations cdc5 (TLG206), cdc14 
(TLG208), cdc15 (TLG285), and esp1 (TLG277) were used to arrest cells 
in late mitosis. Cultures were grown as described in the previous section 
except at 25°C. When cultures reached a density of 0.5–1.0 × 10
7 cells/ml, 
they were shifted to 34°C for 2–4 h.
Northern blot analysis
Strains were grown in YPD at 25°C to a density of 0.7–0.8 × 10
7 cells/ml. 
Half of the culture was harvested and washed, and the RNA was 
  extracted as previously described (Schmitt et al., 1990). The other half 
of the culture was shifted to 37°C for 3 h, after which time RNA was 
  extracted. Equal amounts of whole-cell RNA were separated on a 1% 
agarose and 2.2 M formaldehyde gel and then transferred to a nylon 
membrane (Sambrook and Russell, 2001). Northern blots were probed 
using a 1,360-bp HindIII–SpeI fragment of the CLB2 structural gene 
  radio-labeled with α-[
32P]dCTP using the Prime-it kit (Stratagene). After 
a 12-h hybridization at 42°C, the membrane was washed three times 
at 45°C in 1× SSPE and 0.1% SDS and then three times at 45°C in 
0.1% SSPE and 0.1% SDS. The hybridized blot was analyzed 
on a phosphoimager.
Synthetic genetic interactions
Yeast deletion strains were obtained from the Euroscarf gene knockout 
collection, derived from strain BY4741. These were crossed to the RNase 
MRP RNA mutant nme1-P6 in the strain yJA203, in which the chromo-
somal NME1 gene was replaced with NME1::nme1-p6-NAT. The RNase 
MRP mutation in this strain is masked by a plasmid-borne wild-type copy. 
Diploids were sporulated, and 20 tetrads were dissected for each cross. 
Three tetrads were selected from each veriﬁ  ed interaction, and the level of 
growth defect was quantiﬁ  ed by serial dilution and plating of haploid dou-
ble-mutant cells alongside haploid single-mutant cells, both in the presence 
and absence of 5-ﬂ  uoroorotic acid (5-FOA). Complete absence of growth 
for the haploid double-mutant cells compared with the haploid single-mu-
tant cells on 5-FOA indicated a synthetically lethal genetic interaction. 
Reduced growth for the haploid double-mutant cells compared with the 
haploid single-mutant cells on 5-FOA indicated a growth-defective genetic 
interaction.
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